Cefmatilen
Alternative Names: S 1090Latest Information Update: 09 Jul 2002
At a glance
- Originator Shionogi
- Class Antibacterials; Cephems; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 09 Jul 2002 Discontinued - Phase-III for Bacterial infections in Japan (PO)
- 29 May 2001 Cefmatilen is available for licensing (http://www.shionogi.co.jp)
- 24 Nov 1997 Phase-III clinical trials for Bacterial infections in Japan (PO)